LON:GENI GENinCode (GENI) Share Price, News & Analysis GBX 0.59 -0.01 (-1.33%) As of 06:43 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsNews and Trends About GENinCode Stock (LON:GENI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GENinCode alerts:Sign Up Key Stats Today's Range 0.59▼ 0.6550-Day Range 0.58▼ 1.0552-Week Range 0.50▼ 4.90Volume9.99 million shsAverage Volume4.79 million shsMarket Capitalization£4.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Read More Receive GENI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENI Stock News HeadlinesGENinCode Reports £1.1 Million H1 Revenue as Adjusted EBITDA Loss NarrowsSeptember 29, 2026 | uk.finance.yahoo.comGENinCode Plc Reports Earnings Results for the Half Year Ended June 30, 2026September 29, 2026 | marketscreener.comMLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for $29.97, but it's available as a free download for a limited time.November 9 at 1:00 AM | Profits Run (Ad)GENinCode shares fall after revenue outlook cut and cash runway warningSeptember 29, 2026 | uk.finance.yahoo.comGENinCode sets date for interim results as genetic risk platform gains strategic momentumSeptember 22, 2026 | tipranks.comGENinCode shares rise over 18% intraday after coronary disease test results presented at European conferenceAugust 28, 2026 | uk.finance.yahoo.comGENinCode PLCJuly 30, 2026 | marketwatch.comGENinCode Shareholders Approve All Resolutions at Annual General MeetingJuly 1, 2026 | tipranks.comSee More Headlines GENI Stock Analysis - Frequently Asked Questions How have GENI shares performed this year? GENinCode's stock was trading at GBX 2.50 at the beginning of 2026. Since then, GENI shares have decreased by 76.3% and is now trading at GBX 0.59. How were GENinCode's earnings last quarter? GENinCode Plc (LON:GENI) released its quarterly earnings results on Tuesday, September, 29th. The company reported GBX (0.38) earnings per share for the quarter. GENinCode had a negative net margin of 202.42% and a negative trailing twelve-month return on equity of 481.34%. How do I buy shares of GENinCode? Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings9/29/2026Today11/09/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolLON:GENI CIKN/A Webwww.genincode.com Phone44 1865 955 847FaxN/AEmployees2,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (1.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£6.10 million Net Margins-202.42% Pretax MarginN/A Return on Equity-481.34% Return on Assets-63.99% Debt Debt-to-Equity Ratio4.75 Current Ratio2.22 Quick Ratio15.89 Sales & Book Value Annual Sales£2.60 million Price / Sales1.72 Cash FlowGBX 0.71 per share Price / Cash Flow0.83 Book ValueGBX 1.63 per share Price / Book0.36Miscellaneous Outstanding Shares753,041,000Free FloatN/AMarket Cap£4.46 million OptionableNot Optionable Beta0.59 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (LON:GENI) was last updated on 11/9/2026 by MarketBeat.com Staff. From Our PartnersTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredOne bank just ran the numbers on gold for the next 5 yearsDeutsche Bank's research team just modeled where gold could land by 2031 if central banks keep shifting reserv...Cedar Gold Group | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredElon's Terrifying Warning: America Is "1,000% Going Bankrupt"The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Effic...American Hartford Gold | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GENI Stock Alerts